These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8579513)

  • 1. [Cardiovascular disease and hormone replacement therapy].
    Aldrighi JM; Martinez TL; da Silva Filho CP
    Arq Bras Cardiol; 1995 Sep; 65(3):249-54. PubMed ID: 8579513
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone replacement therapy and cardiovascular disease.
    McPherson R; Tardif JC; Jolly E
    Can J Cardiol; 2001 Nov; 17 Suppl D():32D-37D. PubMed ID: 11726994
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines advise against hormone replacement therapy for cardiovascular disease prevention.
    Rollins G
    Rep Med Guidel Outcomes Res; 2001 Aug; 12(17):7-9. PubMed ID: 12296365
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy and haemostatic function.
    Meade TW
    Thromb Haemost; 1997 Jul; 78(1):765-9. PubMed ID: 9198253
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular disease in women: implications of hormone replacement therapy.
    Sarrel PM
    Int J Fertil Menopausal Stud; 1996; 41(2):90-3. PubMed ID: 8829704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal hormone replacement therapy and cardiovascular disease.
    Chae CU; Ridker PM; Manson JE
    Thromb Haemost; 1997 Jul; 78(1):770-80. PubMed ID: 9198254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormone replacement therapy and cardiovascular risk].
    Maffei S; De Caterina R
    G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of hormone replacement therapy on the cardiovascular system].
    Payer J
    Cas Lek Cesk; 2001 Feb; 140(3):67-9. PubMed ID: 11284420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
    Kovacev-Zavisić B; Icin T; Kovacev N
    Med Pregl; 2009; 62 Suppl 3():85-90. PubMed ID: 19702123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Estrogen and cardiovascular diseases].
    Mikkola T; Tikkanen MJ
    Duodecim; 2003; 119(22):2191-7. PubMed ID: 14702808
    [No Abstract]   [Full Text] [Related]  

  • 12. [Further recognize the benefit and risk of postmenopausal hormone replacement therapy on atherosclerotic cardiovascular diseases].
    Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):321-3. PubMed ID: 12947970
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hormone replacement therapy and prevention of postmenopausal cardiovascular diseases].
    Grand A
    Ann Cardiol Angeiol (Paris); 1998; 47(7):481-7. PubMed ID: 9772970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of cardiovascular risk in menopause women: role of ovarian hormones].
    Rosano GM; Leonardo F; Ricci S; Serra GB; Chierchia SL
    Ann Ist Super Sanita; 1997; 33(2):199-202. PubMed ID: 9470240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological and practical aspects of hormone replacement therapy: an approach to cardiovascular disease prevention in postmenopausal women].
    da Silva PM
    Rev Port Cardiol; 1999 Nov; 18(11):1047-55. PubMed ID: 10608165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease.
    Hodis HN; Mack WJ; Lobo RA
    Circulation; 2003 Jul; 108(1):e5; author reply e5. PubMed ID: 12847059
    [No Abstract]   [Full Text] [Related]  

  • 17. Focus on cardiovascular health: hormone replacement therapy, estrogen replacement therapy, and selective estrogen receptor modulators.
    Walsh BW
    J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S6-8. PubMed ID: 12625632
    [No Abstract]   [Full Text] [Related]  

  • 18. [Are transdermic estrogens cardioprotective?].
    Blümel JE; Campodónico I
    Rev Med Chil; 2001 Apr; 129(4):433-40. PubMed ID: 11413997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of estrogen/androgen therapy. Menopausal symptoms, bone, and cardiovascular parameters.
    Barrett-Connor E
    J Reprod Med; 1998 Aug; 43(8 Suppl):746-52. PubMed ID: 9750204
    [No Abstract]   [Full Text] [Related]  

  • 20. Controversies regarding hormone therapy: Insights from inflammation and hemostasis.
    Koh KK; Yoon BK
    Cardiovasc Res; 2006 Apr; 70(1):22-30. PubMed ID: 16412400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.